Drugdu.com expert's response:

When conducting foreign trade in pharmaceuticals and medical devices, some overseas buyers, after confirming product specifications and prices, will further ask: "Can you support product registration in our country?"

This question may seem straightforward to suppliers. If an enterprise holds relevant certificates such as GMP, CE, or ISO 13485, or has past export experience, it can easily reply directly that it can support registration. However, the "registration support" mentioned by buyers may involve far more work than just providing a few certificates.

Especially for pharmaceuticals, APIs and medical devices, there are significant differences in registration pathways, application entities, technical documents and approval requirements across different countries. The fact that a supplier can provide product materials does not mean these materials already meet local registration requirements; nor does the fact that a product has been approved for marketing in one market mean it can directly enter another.

What Are Overseas Buyers Usually Confirming When They Raise Registration Requirements?

Some overseas buyers have already finalized their target products and are looking for manufacturers that can cooperate in long-term registration; some distributors are preparing to develop new product lines and need to judge the registration cost and feasibility in advance; others are still in the project evaluation stage, only comparing the document support capabilities of different suppliers.

For example, a Middle Eastern medical device distributor looking for a new supplier of patient monitors may, after initially confirming product parameters and quotations, inquire whether the manufacturer can provide CE-related documents, ISO 13485 certificates, technical data, product manuals and manufacturer authorization documents. These materials may be used for local registration or import access assessment, but the final judgment still needs to be combined with the product classification and regulatory requirements of the target country.

If an overseas pharmaceutical enterprise is procuring APIs, its focus may fall on GMP compliance, DMF or ASMF dossiers, quality standards, stability data, impurity control, and whether the manufacturer can cooperate in supplementing materials during the registration process. Some API master files also involve regulatory submission and authorized referencing of confidential information. For instance, the WHO APIMF procedure distinguishes between the public part and the confidential part, and sets up an authorization and referencing mechanism.

These scenarios indicate that when overseas buyers ask if registration can be supported, they have usually begun to consider the conditions required for the product to enter the local market. However, this does not mean the procurement is confirmed, nor does it mean the buyer will place an order immediately.

What Materials Should Suppliers Prepare in Advance?

For enterprises with overseas promotion plans, it is recommended to first establish a basic document list for each product, clarifying which materials are already available, which need to be updated, and which must be re-prepared according to the target market.

Medical device enterprises usually need to organize product specifications, intended use, model lists, manufacturer information, applicable quality management system documents, relevant conformity assessment documents, test reports, risk management materials, clinical evaluation-related data, as well as instructions for use and labels. The specific scope of provision should be determined according to the product risk level, target market and local registration pathway. For example, EU MDR and IVDR also set separate responsibility requirements for manufacturers, authorized representatives, importers and distributors. A single CE-related document cannot prove that all registration obligations have been fulfilled.

Pharmaceutical and API enterprises need to prepare quality standards, COAs, production process-related materials, GMP compliance documents, stability data, impurity research materials and corresponding registration support documents according to product types. For products involving master files such as DMF and ASMF, it is also necessary to confirm whether the dossier has been established, whether it is applicable to the target regulatory system, and whether the enterprise can provide authorized referencing or directly submit relevant materials to the regulatory authority in accordance with regulations.

It is important to note that an enterprise holding a certain certificate is completely different from the product having obtained marketing authorization in a specific country. For example, the US FDA clearly states that the completion of facility registration and product listing by a medical device enterprise does not mean that its product has obtained FDA approval or 510(k) clearance. Suppliers should avoid confusing these different statuses when introducing their registration capabilities to foreign parties.

For enterprises that temporarily have no registration experience in the target market, there is no need to give up all relevant inquiries. They can first confirm whether the existing materials are complete, whether English versions are available, whether the manufacturer is willing to cooperate in local registration, and which additional tests or documents require separate evaluation. For buyers, an accurate description of the status of existing documents is usually more valuable for reference than a vague promise of "registration support".

Registration Support Also Involves Follow-Up Cooperation Capabilities

Overseas registration does not necessarily end after the first batch of documents is submitted. Regulatory authorities may require supplementary information; importers may need authorization documents issued by the manufacturer; product instructions and labels may also need to be adjusted in accordance with local requirements.

If changes occur in the production address, key raw materials, manufacturing process, design or performance of the product after registration or marketing, it may involve change assessment, dossier update or even re-submission of the application. The specific requirements vary by market and product.

Therefore, when evaluating suppliers, buyers will not only care about which documents can be provided, but also consider whether the enterprise can continue to cooperate.

This is also one of the reasons why some enterprises, despite their competitive product prices, find it difficult to enter long-term overseas procurement projects. Buyers need more than just the ability to deliver goods at present; they also need to confirm that the two parties can maintain stable cooperation in future processes including registration, quality audit, change management and continuous supply.

Of course, suppliers also need to clarify the boundary of responsibilities. Questions such as who will apply for local registration, who will bear the registration fees, who will translate the technical documents, what the scope of manufacturer authorization covers, who will hold the registration certificate or license, and how to handle matters after the cooperation terminates, should be gradually clarified as the project moves forward. For parts involving confidential production processes and technical information, enterprises should also protect their own information through non-disclosure agreements and appropriate dossier submission methods.

For potential buyers whose cooperation has not yet been confirmed, suppliers can first provide basic specifications, public qualifications and a list of available documents. For materials involving complete technical dossiers, confidential processes or official authorizations, they can be arranged as needed after the buyer's identity, target market, registration pathway and cooperation conditions are clarified.

An Enterprise's Registration Support Capability Should Also Be Reflected in Its Product Display

Many enterprises, when uploading products on B2B platforms, focus on displaying images, specifications and prices, but rarely specify which registration-related documents the product currently has.

For example, a medical device page only states "CE Certified" without specifying the involved specific product models or document scope; an API product only marks "GMP Available", leaving buyers still unaware of the corresponding production entity, quality standards and whether DMF-related support can be provided.

Unclear information in this regard may prevent buyers from judging whether the product is suitable for their market during the initial screening stage.

For enterprises preparing to expand overseas business, they can appropriately state their existing quality systems, applicable product standards, relevant document support and target market registration experience in product details. For confidential information, it is sufficient to note that it can be provided during the project evaluation stage, and there is no need to upload all documents publicly. On professional pharmaceutical B2B platforms such as Drugdu.com, enterprises can display relevant qualifications and supply capabilities through product pages and company profiles. For overseas procurement projects requiring registration support, clear product information can help buyers judge whether the supplier has the foundation for further communication, and also facilitate subsequent inquiries to enter a more specific procurement evaluation stage.

When an overseas buyer asks whether a product can support local registration, it means they have begun to pay attention to the feasibility of the product entering the target market. As for whether the project is mature, it depends on whether the other party can clarify the target country, product specifications, registration entity, estimated timeline and specific document requirements.

For suppliers, their registration support capability does not need to cover all countries from the very beginning. A more practical approach is to first organize documents around key export products and target markets, clarifying existing documents, documents to be supplemented, and the scope of cooperation that can be provided. When a buyer raises a registration question, the enterprise that can clearly state which materials are already available, which require further evaluation, and to what extent follow-up cooperation can be carried out, has already laid a good foundation for the two parties to continue discussing the procurement project.